Back
UroGen Pharma Vs. UniFirst Industry Stock Comparison
Sell
23
URGN
UroGen Pharma
Last Price:
$11.02
Seasonality Move:
-4.35%
Buy
73
UNF
UniFirst
Last Price:
$214.87
Seasonality Move:
1.02%
Sell
23
UroGen Pharma (URGN)
is a Sell
Is UroGen Pharma a Buy, Sell or Hold?
-
The current UroGen Pharma [URGN] share price is $11.04. The Score for URGN is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URGN Stock Price Chart
What is UroGen Pharma's stock price today?
-
The UroGen Pharma share price today is $11.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight buying pressure.
URGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 45.54 | Sell |
Chaikin Money Flow: | 72936 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.69 - 11.89) | Sell |
Bollinger Bands (100): | (11.37 - 13.59) | Sell |
UNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 72.95 | Buy |
Chaikin Money Flow: | 380542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (173.47 - 198.41) | Buy |
Bollinger Bands (100): | (180.75 - 197.95) | Buy |
URGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.87 | Buy |
20-day SMA: | 11.03 | Buy |
50-day SMA: | 11.71 | Sell |
200-day SMA: | 13.66 | Sell |
8-day EMA: | 10.97 | Buy |
20-day EMA: | 11.13 | Sell |
50-day EMA: | 11.66 | Sell |
200-day EMA: | 13.18 | Sell |
UNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 180.62 | Buy |
20-day SMA: | 183.05 | Buy |
50-day SMA: | 190.15 | Buy |
200-day SMA: | 178.74 | Buy |
8-day EMA: | 187.59 | Buy |
20-day EMA: | 185.11 | Buy |
50-day EMA: | 187.72 | Buy |
200-day EMA: | 182.46 | Buy |
UroGen Pharma Earnings Growth & URGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $2.30 per share.
UniFirst Earnings Growth & UNF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.98 per share, a decrease this year of $0.14 per share, and an increase next year of $0.92 per share.
UroGen Pharma Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UniFirst Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |